共 287 条
- [1] Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts[J]. Alcorta, DA;Xiong, Y;Phelps, D;Hannon, G;Beach, D;Barrett, JC. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996(24)
- [2] Functional analysis of wild-type and malignant glioma derived CDKN2A beta alleles: Evidence for an RB-independent growth suppressive pathway[J]. Arap, W;Knudsen, E;Sewell, DA;Sidransky, D;Wang, JYJ;Huang, HJS;Cavenee, WK. ONCOGENE, 1997(17)
- [3] Balazs M, 1997, GENE CHROMOSOME CANC, V19, P84, DOI 10.1002/(SICI)1098-2264(199706)19:2<84::AID-GCC3>3.3.CO
- [4] 2-U
- [5] FREQUENT MUTATIONS OF CDKN2 IN PRIMARY PANCREATIC ADENOCARCINOMAS[J]. BARTSCH, D;SHEVLIN, DW;TUNG, WS;KISKER, O;WELLS, SA;GOODFELLOW, PJ. GENES CHROMOSOMES & CANCER, 1995(03)
- [6] p14ARF links the tumour suppressors RB and p53[J]. Bates, S;Phillips, AC;Clark, PA;Stott, F;Peters, G;Ludwig, RL;Vousden, KH. NATURE, 1998(6698)
- [7] Batova A, 1997, CANCER RES, V57, P832
- [8] Baud E, 1999, INT J ONCOL, V14, P441
- [9] Frequent methylation silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-cell and T-cell lymphomas[J]. Baur, AS;Shaw, P;Burri, N;Delacrétaz, F;Bosman, FT;Chaubert, P. BLOOD, 1999(05)
- [10] Benassi MS, 1999, INT J CANCER, V84, P489, DOI 10.1002/(SICI)1097-0215(19991022)84:5<489::AID-IJC7>3.0.CO